Amid heightened public concern, the cost of prescription drugs is a focus of attention by the Biden administration and lawmakers in Congress and state capitals. Proposed actions range from allowing Medicare to negotiate the prices of certain drugs to limiting some drug price increases to inflation and capping out of pocket costs for Medicare beneficiaries in Part D, among other initiatives. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources
Related Prescription Drugs Resources
- Insulin Out-of-Pocket Costs in Medicare Part D
- Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020
- Out-of-pocket spending on insulin among people with private insurance
- How Do Prescription Drug Costs in the United States Compare to Other Countries?
- Public Opinion on Prescription Drugs and Their Prices
- Insulin Costs and Coverage in Medicare Part D
- Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act
- The Public Weighs In On Medicare Drug Negotiations
- Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending
- Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage
- 10 FAQs on Prescription Drug Importation
- Medicaid Outpatient Prescription Drug Trends During the COVID-19 Pandemic
- Prescription Drug Rebates, Explained
- Who is most likely to have high prescription drug costs?
- Latest News on Prescription Drugs from Kaiser Health News
How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries?
The brief provides a quick explainer of the prescription drug provisions in legislative text released by the Senate Finance Committee to be included in a forthcoming reconciliation bill and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.
Issue Brief See More
Refine Results
- view as grid
- view as list
Florida’s Medicaid Prescription Drug Benefit: A Case Study
Florida's Medicaid Prescription Drug Benefit: A Case StudyA new study summarizes and discusses the state s attempt to reform its Medicaid prescription drug benefit program. Background Paper
Report Read More Medicaid: Purchasing Prescription Drugs
Medicaid: Purchasing Prescription DrugsA policy brief explaining how Medicaid purchases outpatient drugs and outlining the policy tools available to states to limit the rate of growth in spending on prescription drugs. Policy Brief (28 pages)
Issue Brief Read More Outpatient Prescription Drug Benefits Under Medicaid: Detailed Case Studies
A report on Indiana, Massachusetts, Montana, North Carolina, Oregon, and Pennsylvania prescription drug programs illustrating the issues and challenges for delivering drugs via Medicaid, managed care, and pharmaceutical assistance programs.Report
Report Read More Medicare Chartbook
The Medicare Chartbook includes data and background information critical to understanding the Medicare program and the challenges it faces in keeping up with the rising costs of health care and in ensuring the program s future financial security.
Report Read More Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising
Direct-to-consumer prescription drug advertising, particularly television advertising, has grown rapidly in the last few years. This nationally representative survey examines how consumers who are shown specific television prescription drug ads respond to such ads: what information they retain, what actions they predict they will take, and their views about this…
Report Read More Prescription Drug Trends: A Chartbook Update
This November 2001 Chartbook updates data from last year’s chartbook, including information about prescription drug coverage, expenditures and prices, utilization, drug promotion, and the pharmaceutical industry.
Report Read More Health News Index – July/August 2001
Health News Index July/August, 2001 The July/August 2001 edition of the Kaiser Family Foundation/Harvard School of Public Health, Health News Index includes questions about major health stories covered in the news, including stem cell research and patients rights legislation. The Health News Index is designed to help the news media…
Poll Finding Read More Medicare and Prescription Drug Focus Groups
Summary Report This report, : Summary Report, produced jointly by the bipartisan team of Bill McInturff of Public Opinion Strategies and Geoff Garin of Peter D. Hart Research Associates, presents key findings from a series of eight focus groups on the Medicare program and the current debate over prescription drug…
Report Read More Health News Index – May/June 2001
Health News Index May/June, 2001 The May/June 2001 edition of the Health News Index includes questions about major health stories covered in the news, including the Supreme Court ruling regarding the distribution of medical marijuana and the debate in Congress over a Patients Bill of Rights. This edition also includes…
Poll Finding Read More Targeting Medicare Drug Benefits: Costs and Issues
This report, written by Marilyn Moon and Matthew Storeygard of the Urban Institute, estimates the potential cost of targeting drug benefits to low-income Medicare beneficiaries and those with catastrophic drug expenses and discusses some of the key programmatic issues that could arise under this approach. The authors predict that a…
Report Read More